ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research

$300,000 in Research Grants Awarded as Part of its Ongoing Annual Research Awards Program

Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of twelve research grants to universities under the company’s fourteenth Annual Research Award Program.

“Align is delighted to announce the awards for research that leads to insights and evidence that advance the applicability of treatment for patients of all ages. We are pleased to support university research around the world in the orthodontic and dental fields,” said Dr. Mitra Derakhshan, Align executive vice president, chief clinical officer, global treatment planning and clinical services. “We are excited to learn about the findings from all of the awarded research and any future publications.”

The Americas research award recipients for 2024 are:

  • University of Washington (Seattle, WA) - Primary Investigator, Dr. Sanghee Lee
  • University of Florida (Gainesville, FL) - Primary Investigator, Dr. Sarah Hisham Abu Arqub
  • University of California San Francisco (San Francisco, CA) - Primary Investigator, Dr. Christine Hong
  • University of Kentucky (Lexington, KY) - Primary Investigator, Dr. Mohamed Bazina

The European research award recipients for 2024 are:

  • UniCamillus International Medical University (Rome, Italy) - Primary Investigator, Dr. Chiara Pavoni
  • University of Insubria (Varese and Como, Italy) - Primary Investigator, Dr. Luca Levrini
  • UniCamillus International Medical University (Rome, Italy) - Primary Investigator, Dr. Roberta Lione
  • University of L’Aquila (L’Aquila, Italy) - Primary Investigator, Dr. Silvia Caruso

The Asia Pacific research award recipients for 2024 are:

  • Sichuan University (Chengdu, China) - Primary Investigator, Dr. Hu Long
  • Institute of Dental Studies and Technologies (Kadrabad, Ghaziabad, India) - Primary Investigator, Dr. Vikas Thakur
  • Chulalongkorn University (Bangkok, Thailand) - Primary Investigator, Dr. Sirichom Satrawaha
  • Ragas Dental College and Hospital (Uthandi, Tamil Nadu, India) - Primary Investigator, Dr. N.R. Krishnaswamy

“This year the number of applications to the program is one of the largest since its initiation fourteen years ago,” said John Morton, Align vice president, technical fellow. “The publications and lectures resulting from these research endeavors advance the science of dentistry and aim to improve the dental care of the global community. We are proud to provide this opportunity to these excellent university researchers throughout the world.”

The funded research studies cover a wide range of topics including: maxillary molar distalization in adult aligner patients, comparing the oral microbiome between fixed orthodontic treatment and compared it to individuals undergoing orthodontic interventions utilizing removable clear aligners, evaluating early mixed dentition treatment, evaluating the effects of different interproximal reduction (IPR) systems on enamel surfaces, comparing the smile esthetics including both objectives (smile arc, buccal corridor and incisor exposure), and evaluating the efficacy of different types of probiotics on biofilm formed around clear aligners.

All award applications received were first reviewed and prioritized in a blind evaluation by an independent academic committee. The final recipients were then determined by Align Technology.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 261 thousand doctor customers and is key to accessing Align’s 600 million consumer market opportunity worldwide. Align has helped doctors treat over 17.6 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.30
+4.85 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.